Literature DB >> 17642991

Occurrence and characterisation of uropathogenic Escherichia coli in urinary tract infections.

R Raksha1, H Srinivasa, R S Macaden.   

Abstract

PURPOSE: To study the occurrence of Uropathogenic Escherichia coli (UPEC) in cases with urinary tract infections.
METHODS: A total of 220 cases from urinary tract infections and 50 stool samples from apparently healthy individuals were included. The colonies identified as Escherichia coli were screened for virulence factors namely haemolysin, Mannose Resistant and Mannose Sensitive Haemagglutination (MRHA, MSHA), Cell surface hydrophobicity and Serum resistance by recommended methods.
RESULTS: Among 220 cases 91(41.36%) were haemolytic, 68(30.9%) showed MRHA, 58(26.36%) were cell surface hydrophobicity positive and 72(32.72%) were serum resistant. In 50 controls 3(6%) were haemolytic, 6(12%) showed MRHA, 9(18%) showed cell surface hydrophobicity and 12(24%) were serum resistant. The difference between cases and controls for haemolysis and MRHA were significant (p< 0.001 and p< 0.01 respectively). A total of 14 atypical Escherichia coli were isolated from urine and all showed the presence of one or the other virulence markers. Out of 18 mucoid Escherichia coli isolated 10 were serum resistant. Interestingly among the 15 Escherichia coli isolated from patients with pyelonephritis 8 were UPEC.
CONCLUSIONS: Out of 220 urinary isolates, 151 could be labelled as UPEC.

Entities:  

Year:  2003        PMID: 17642991

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  14 in total

1.  Evaluation of the virulence markers in the clinical isolates of citrobacter species: the first report from India.

Authors:  Ritu Nayar; Indu Shukla; S Manazir Ali
Journal:  J Clin Diagn Res       Date:  2013-06-01

2.  Antibiotic resistance and virulence properties in Escherichia coli strains from cases of urinary tract infections.

Authors:  Felix Oluwasola Olorunmola; Deboye Oriade Kolawole; Adebayo Lamikanra
Journal:  Afr J Infect Dis       Date:  2013

3.  Protective efficacy and immunogenicity of Escherichia coli K13 diphtheria toxoid conjugate against experimental ascending pyelonephritis.

Authors:  Varinder Kumar; N k Ganguly; Kusum Joshi; Rahul Mittal; Kusum Harjai; Sanjay Chhibber; Saroj Sharma
Journal:  Med Microbiol Immunol       Date:  2005-05-21       Impact factor: 3.402

4.  Differential epidemiology and antibiotic resistance of lactose-fermenting and non-fermenting Escherichia coli: Is it just a matter of taste?

Authors:  Márió Gajdács; Marianna Ábrók; Andrea Lázár; Katalin Burián
Journal:  Biol Futur       Date:  2020-06-04

5.  Transformation of Brevibacillus, a soil microbe to an uropathogen with hemagglutination trait.

Authors:  S C Suneeva; R Prasanth; N G Rajesh; P Viswanathan
Journal:  World J Microbiol Biotechnol       Date:  2014-01-24       Impact factor: 3.312

6.  Hemagglutination and biofilm formation as virulence markers of uropathogenic Escherichia coli in acute urinary tract infections and urolithiasis.

Authors:  Uma B Maheswari; Sunitha Palvai; Pattepu Rajalingam Anuradha; Nagamani Kammili
Journal:  Indian J Urol       Date:  2013-10

7.  Phenotypic study of virulence factors in Escherichia coli isolated from antenatal cases, catheterized patients, and faecal flora.

Authors:  Shruthi N; Ravi Kumar; Ravish Kumar
Journal:  J Clin Diagn Res       Date:  2012-10-26

8.  An approach to uropathogenic Escherichia coli in urinary tract infections.

Authors:  K Prabhat Ranjan; Neelima Ranjan; Arindam Chakraborty; D R Arora
Journal:  J Lab Physicians       Date:  2010-07

9.  Journal of Laboratory Physicians (JLP): Success Story Despite Many Challenges.

Authors:  Sarman Singh
Journal:  J Lab Physicians       Date:  2011-01

10.  Effect of asiatic and ursolic acids on morphology, hydrophobicity, and adhesion of UPECs to uroepithelial cells.

Authors:  Wojnicz Dorota; Kicia Marta; Tichaczek-Goska Dorota
Journal:  Folia Microbiol (Praha)       Date:  2012-11-07       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.